The Les Bleus are going home empty-handed from the Euro 2021.

World champ France has just lost to the Swiss on 5-4 penalty shootout in the QF, after finishing 3-3 in regular time in a goal fest match.

 

To the markets, the ASX 200 fell by more than 0.7 per cent into midday trade.

Tech was the only sector in the green, barely scraping a 0.28 per cent gain.

Cyclical stocks in real estate, utilities, and mining were the main drags, all falling by more than 1 per cent.

Property stocks were being sold off as many are trading ex-dividend today with the end of the 2021 financial year now approaching.

The moves in the ASX this morning have broadly tracked proceedings on Wall Street overnight.

Meanwhile, it was reported by Bloomberg that Cathy Wood has entered into the Bitcoin race, with Ark Investment filing for a Bitcoin ETF on the Cboe BZX Exchange under the ticker ARKB.

WINNERS

Here are the best performing ASX small cap stocks in morning trade for Tuesday, June 29:

Swipe or scroll to reveal the full table. Click headings to sort.

 

Design Milk (ASX:DMC) surged by 10.5 per cent after saying that it anticipated full year sales to come in at $3.3 million, a growth of 88 per cent vs last year.

Digital-X (ASX:DCC) rose by 6 per cent after recognising $8.33m in revenue for advisory services undertaken in FY19.

Digital advertising company GTN (ASX:GTN) jumped 15 per cent, even after downgrading its forecast. The company now expects EBITDA for the year ended 30 June will be in the range of $13 million-$14 million, compared to $14.2 million in the previous year.

Firebird Metals (ASX:FRB) rose by almost 9 per cent after a substantial holder notice revealed major backer Tolga Kumova chipped another $450,000 into the company’s share register.

Meanwhile, a couple of biotech stocks, Nyrada (ASX:NYR) and BARD1 (ASX:BD1) did well this morning after announcing positive updates.

Nyrada rose by as high 7 per cent intraday after reporting encouraging efficacy results from its second pre-clinical vivo study of NYX-PCSK9i to treat patients with cholesterol.

BARD1 also rose by as high as 7 per cent, after announcing that its 2018 study results on antibody tests for ovarian cancer has been published in the internationally respected peer-reviewed journal, Genes.

LOSERS

Here are the best performing ASX small cap stocks in morning trade for Tuesday, June 29:

Swipe or scroll to reveal the full table. Click headings to sort.